tiprankstipranks
Samjin Pharmaceutical Co., Ltd. (KR:005500)
:005500
South Korea Market
005500
Samjin Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Samjin Pharmaceutical Co., Ltd. (005500) Financial Statements

― Followers

Samjin Pharmaceutical Co., Ltd. Financial Overview

Samjin Pharmaceutical Co., Ltd.'s market cap is currently ₩217.46B. The company's EPS TTM is $1869.46; its P/E ratio is 9.86; and it has a dividend yield of 4.34%. Samjin Pharmaceutical Co., Ltd. is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 309.13B₩ 308.35B₩ 292.13B₩ 274.03B₩ 250.07B
Gross Profit₩ 153.03B₩ 128.97B₩ 145.89B₩ 117.73B₩ 117.83B
Operating Income₩ 24.68B₩ 31.64B₩ 19.50B₩ 23.18B₩ 33.91B
EBITDA₩ 44.50B₩ 65.92B₩ 36.60B₩ 36.81B₩ 42.41B
Net Income₩ 24.17B₩ 39.23B₩ 18.91B₩ 21.89B₩ 28.40B
Balance Sheet
Cash & Short-Term Investments₩ 12.91B₩ 3.71B₩ 4.01B₩ 4.66B₩ 11.71B
Total Assets₩ 470.53B₩ 425.17B₩ 419.90B₩ 406.56B₩ 332.50B
Total Debt₩ 135.89B₩ 121.42B₩ 118.64B₩ 87.51B₩ 54.51B
Net Debt₩ 123.81B₩ 118.01B₩ 116.24B₩ 85.17B₩ 46.56B
Total Liabilities₩ 180.14B₩ 163.51B₩ 154.54B₩ 130.69B₩ 98.33B
Stockholders' Equity₩ 290.39B₩ 261.66B₩ 265.36B₩ 275.34B₩ 234.17B
Cash Flow
Free Cash Flow₩ 9.96B₩ 19.81B₩ -12.39B₩ -18.20B₩ -50.64B
Operating Cash Flow₩ 22.23B₩ 38.15B₩ 8.33B₩ 17.29B₩ 23.97B
Investing Cash Flow₩ -24.99B₩ -18.37B₩ -18.25B₩ -70.06B₩ -71.56B
Financing Cash Flow₩ 11.42B₩ -18.77B₩ 9.97B₩ 47.16B₩ 36.62B
Currency in KRW

Samjin Pharmaceutical Co., Ltd. Earnings and Revenue History

Income Statement >

Samjin Pharmaceutical Co., Ltd. Debt to Assets

Balance Sheet >

Samjin Pharmaceutical Co., Ltd. Cash Flow

Cash Flow >

Samjin Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS

Earnings >